Loading...
Guest User
Welcome! Please login.
* - Tentative Dates
The intend to utilise the gross proceeds raised through the Issue (the “Issue Proceeds”) after deducting the Issue-related expenses (“Net Proceeds”) for the below-mentioned Objects (collectively, referred to as the “Objects”):
Valiant Laboratories Limited's revenue decreased by 27% and profit after tax (PAT) dropped by 789% between the financial year ending with March 31, 2025 and March 31, 2024.
| Period Ended | 31 Mar 2025 | 31 Mar 2024 |
| Revenue | 133.38 | 182.06 |
| Profit After Tax | -2.20 | 0.32 |
| Net Worth | 234.31 | 236.86 |
| Reserves and Surplus | 190.86 | 193.41 |
| Amount in ₹ Crore | ||
Valiant Laboratories Limited was originally incorporated in 1980 as a partnership firm under the name of Bharat Chemicals as one of the manufacturers of "Paranitro Phenol" used in the manufacture of pharmaceuticals, fungicides and rubber additives.
It is a company that manufactures active pharmaceutical ingredients (“API”) and bulk drugs, with a focus on the manufacture of paracetamol. Bulk drugs/active pharmaceutical ingredients (API) are used as raw material for the production of finished dosage forms or formulations. Paracetamol (scientific name: acetaminophen or para-hydroxyacetanilide - C8H9NO2) is one of the most commonly taken painkillers in the world and is recommended by the World Health Organisation (WHO) as the first choice for pain conditions.
Paracetamol is used to treat headaches, muscle pain, arthritis, back pain, toothache, colds and fever, among other things. The company manufactures paracetamol in various grades such as IP/BP/EP/USP to meet the pharmacopoeial requirements of its customers.
The plant is equipped with the latest instruments and equipment to fulfil customer requirements and also offers various API grades according to customer requirements. The manufacturing facility is strategically located 150 km from Nhava Sheva Port (JNPT) and about 110 km from the company's headquarters in Mumbai.
